Close

UPDATE: Synergy Pharma (SGYP) Higher on Linzess Approval (IRWD) (FRX)

August 30, 2012 11:00 AM EDT
(Updated - August 30, 2012 11:36 AM EDT)

Synergy Pharmaceuticals (Nasdaq: SGYP) is moving higher following FDA approval for Linzess for Ironwood (Nasdaq: IRWD) and Forest Labs (NYSE: FRX). Shares are up 3 percent on the session.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Insiders' Blog, Trader Talk